Psychiatry · Salinas, CA
NPI
1578517538
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
160 Harden Pkwy, Suite 102
Salinas, CA, 93906
Phone (831) 449-1600
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$511K
621 prescriptions
Company payments, 2025
$284
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug John R Donaldson III prescribed most often to Medicare patients was Nuedexta (Dextromethorphan Hbr/Quinidine), with 63 prescriptions and refills. In total John R Donaldson III wrote 621 Medicare prescriptions that cost $511K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Nuedexta Dextromethorphan Hbr/Quinidine | 63 | 63 | Under 11 | $218K |
| Rexulti Brexpiprazole | 57 | 58 | Under 11 | $85K |
| Clonazepam Generic | 52 | 54 | Under 11 | $661 |
| Lamotrigine Generic | 52 | 78 | Under 11 | $729 |
| Gabapentin Generic | 44 | 54 | Under 11 | $451 |
| Alprazolam Xr Alprazolam | 34 | 34 | Under 11 | $735 |
| Nuplazid Pimavanserin Tartrate | 31 | 37 | Under 11 | $188K |
| Quetiapine Fumarate Generic | 31 | 47 | Under 11 | $234 |
| Zolpidem Tartrate Generic | 29 | 29 | Under 11 | $28.04 |
| Trazodone Hcl Generic | 25 | 25 | Under 11 | $123 |
| Olanzapine Generic | 20 | 28 | Under 11 | $309 |
| Ziprasidone Hcl Generic | 15 | 17 | Under 11 | $510 |
| Ropinirole Hcl Generic | 13 | 13 | Under 11 | $74.55 |
| Prazosin Hcl Generic | 12 | 12 | Under 11 | $834 |
| Alprazolam Generic | 12 | 12 | Under 11 | $237 |
Brand drugs: 203 claims; generic drugs: 418 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John R Donaldson III $284 ($284 in general payments such as food, travel and fees) from 3 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $197.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.